Skip to main content
. Author manuscript; available in PMC: 2024 Mar 8.
Published in final edited form as: Biochemistry. 2021 Apr 6;60(15):1201–1213. doi: 10.1021/acs.biochem.1c00128

Table 1.

Stoichiometries and Kinetics of Protease Inhibition by Antithrombin Variantsa

AT variant SI−H k a,−H SIH5 k a,H5 ka,H5/
ka,−H
SIH50 k a,H50 ka,H50/
ka,H5
Thrombin Reactions
wild type 1.2 ± 0.1 (1.1 ± 0.2) × 104 1.3 ± 0.1 (2.3 ± 0.3) × 104 2.1 1.7 ± 0.1 (3.4 ± 0.5) × 107 1500
V375C/S380C 1.8 ± 0.2 (3.8 ± 0.1) × 103 2.4 ± 0.3 (5.0 ± 0.9) × 103 1.3 2.8 ± 0.1 (2.2 ± 0.6) × 107 4400
L373C/S380C 1.2 ± 0.1 (6.4 ± 0.7) × 103 1.2 ± 0.1 (7.7 ± 0.8) × 103 1.2 1.7 ± 0.1 (9.2 ± 1.7) × 106 1200
K222C/E381C 1.4 ± 0.1 (5.3 ± 0.4) × 103 2.5 ± 0.1 (9.0 ± 0.6) × 103 1.7 14 ± 1 (4.1 ± 0.4) × 107 4600
K222C/K139C 1.1 ± 0.1 (1.3 ± 0.2) × 104 1.1 ± 0.1 (8.5 ± 1.2) × 103 0.7 2.9 ± 0.2 (2.6 ± 0.3) × 107 3100
S380C 1.0 ± 0.1 (8.1 ± 0.9) × 103 1.5 ± 0.2 (2.0 ± 0.6) × 107 2500b
helix D 1.4 ± 0.1 (1.1 ± 0.3) × 104 1.6 ± 0.1 (1.3 ± 0.2) × 104 1.2 1.8 ± 0.1. (8.5 ± 1.4) × 106 650
helix D/L373C/S380C 1.8 ± 0.2 (5.9 ± 2.6) × 103 2.6 ± 0.1 (9.1 ± 1.9) × 103 1.5 3.4 ± 0.2 (3.0 ± 0.2) × 106 330
Y131L 1.5 ± 0.1 (1.3 ± 0.2) × 104 1.6 ± 0.1 (2.3 ± 0.2) × 104 1.8 2.5 ± 0.1 (2.1 ± 0.3) × 107 910
Y131L/V375C/S380C 60 ± 2 (7.9 ± 1.0) × 103 79 ± 5 (1.0 ± 0.2) × 104 1.3 68 ± 7 (1.3 ± 0.2) × 107 1300
S380W 14 ± 1 (1.0 ± 0.1) × 104 8.8 ± 0.2 (2.5 ± 0.1) × 104 2.5 25 ± 1 ND
Y131L/S380W 6.7 ± 0.5 (9.5 ± 1.1) × 103 4.2 ± 0.2 (1.2 ± 0.1) × 104 1.3 13 ± 1 (3.6 ± 0.4) × 106 300
Factor Xa Reactions
wild type 1.2 ± 0.1 (4.0 ± 0.8) × 103 1.8 ± 0.3 (1.4 ± 0.3) × 106 350 2.1 ± 0.1 (1.8 ± 0.1) × 107 13
V375C/S380C 2.0 ± 0.4 (5.3 ± 1.3) × 102 5.6 ± 0.8 (1.6 ± 1.0) × 105 300 5.0 ± 0.3 (7.0 ± 0.9) × 106 44
L373C/S380C 1.2 ± 0.1 (6.5 ± 0.7) × 102 2.0 ± 0.1 (2.2 ± 0.3) × 105 340 2.0 ± 0.2 (4.0 ± 0.8) × 106 18
K222C/E381C 2.3 ± 0.1 (4.1 ± 0.4) × 102 4.7 ± 0.3 (7.0 ± 1.8) × 102 1.7 10 ± 1 (1.1 ± 0.2) × 105 160
K222C/K139C 1.1 ± 0.1 (2.6 ± 0.3) × 103 2.0 ± 0.1 (1.5 ± 0.2) × 105 58 7.7 ± 1.4 (2.4 ± 0.5) × 106 16
S380C 1.2 ± 0.1 (1.6 ± 0.2) × 103 1.9 ± 0.1 (6.3 ± 0.7) × 105 750
helix D 1.4 ± 0.1 (3.1 ± 0.6) × 105 2.2 ± 0.3 (1.0 ± 0.2) × 106 3.2 5.6 ± 0.8 (2.4 ± 0.6) × 107 24
helix D/L373C/S380C 2.3 ± 0.1 (6.9 ± 1.0) × 103 4.2 ± 0.3 (4.0 ± 0.4) × 105 58 5.1 ± 0.6 (1.3 ± 0.3) × 106 3.3
Y131L 1.7 ± 0.2 (4.7 ± 0.9) × 104 1.8 ± 0.2 (8.4 ± 1.6) × 105 18 1.8 ± 0.2 (2.6 ± 0.4) × 106 3.1
Y131L/V375C/S380C 65 ± 5 (1.5 ± 0.3) × 103 180 ± 3 (5.4 ± 0.3) × 105 360 69 ± 2 (2.0 ± 0.1) × 106 3.7
S380W 28 ± 2 (1.3 ± 0.2) × 104 82 ± 4 (6.0 ± 1.0) × 105 46 55 ± 2 (2.9 ± 0.4) × 106 4.8
Y131L/S380W 19 ± 1 (8.9 ± 1.2) × 104 32 ± 2 (5.4 ± 1.0) × 105 6.1 28 ± 1 (2.8 ± 0.3) × 106 5.2
Factor IXa Reactions
wild type 1.0 ± 0.1 (1.8 ± 0.3) × 102 1.0 ± 0.1 (2.5 ± 0.4) × 104 140 1.1 ± 0.1 (6.0 ± 0.8) × 106 240
V375C/S380C ND (3.9 ± 0.1) × 100c 5.6 ± 0.4 (7.8 ± 1.1) × 103 >360c 7.3 ± 0.7 (1.2 ± 0.3) × 107 1500
L373C/S380C ND (2.1 ± 0.8) × 100c 1.4 ± 0.1 (7.6 ± 1.5) × 103 >2600c 1.4 ± 0.1 (4.8 ± 0.9) × 105 63
K222C/E381C ND (0.2 ± 0.1) × 100c ND (0.2 ± 0.1) × 100c 1 2.8 ± 0.2 (4.5 ± 0.9) × 102 >800c
K222C/K139C ND (5.2 ± 0.1) × 10c 2.0 ± 0.2 (7.6 ± 1.0) × 103 150
S380C 1.0 ± 0.1 (2.7 ± 0.2) × 10 1.0 ± 0.1 (1.3 ± 0.1) × 104 480
helix D 1.4 ± 0.1 (1.8 ± 0.2) × 104 1.3 ± 0.4 (2.9 ± 1.4) × 104 1.6
helix D/L373C/S380C ND (1.2 ± 0.1) × 10c 2.3 ± 0.1 (9.2 ± 0.6) × 103 >330c
a

Stoichiometries of inhibition (SI) and second-order association rate constants (ka) for antithrombin–protease reactions were determined in I = 0.15 sodium phosphate buffer for thrombin reactions or in I = 0.15 Hepes/calcium buffer for FXa and FIXa reactions, all at pH 7.4 and 25 °C in the absence of heparin (−H), in the presence of heparin pentasaccharide (+H5), or in the presence of full-length heparin (+H50), as described in Materials and Methods. All measurements were made at least in duplicate with errors representing the range or standard error. Heparin allosteric activation rate enhancements are indicated by the kH5/k−H ratio, and heparin bridging rate enhancements are indicated by the kH50/kH5 ratio.

b

The ratio represents ka,H50/ka,−H.

c

Apparent values of ka because slow reaction rates precluded measurement of SIs. Lower limits of rate enhancements are based on corrections of apparent ka values assuming SIs no greater than those measured in the presence of heparin.